Polyploid cisplatin-resistant cancer cells have altered nuclear organization and epigenomic status.

Chemotherapy resistance remains a critical barrier in cancer treatment, partly driven by polyploid cells that survive therapy and contribute to tumor recurrence. Here, we investigated epigenomic and transcriptional changes associated with cisplatin-s…

Preview only. Read the full abstract at the source